CAH-L and CAH-H could restore hepatic SOD and catalase activities and decrease hepatic MDA levels (p < 0.01, 0.001), but only CAH-H restored hepatic GPx and GR activities (p < 0.05) (Figure 3 and Figure 4). The gene discussed is GSR; the disease is congenital adrenal hyperplasia.